MMC vs MPLT · P/E 22, rev $24.46B vs $1.24B cap
Marsh & McLennan Companies Inc (MMC) versus MapLight Therapeutics, Inc. Common Stock (MPLT) — a side-by-side from cached financials, not a winner call.
Marsh & McLennan Companies Inc (MMC) is a insurance brokers company listed on US.
MapLight Therapeutics, Inc. Common Stock (MPLT) is a biotechnology company listed on NASDAQ.
Latest reported MMC revenue for 2024-12-31 was $24.46B. Net income was $4.12B. Revenue was up 7.6% from 2023-12-31 to 2024-12-31. MMC currently screens at market cap $89.82B and trailing P/E 21.9.
MPLT does not have a complete income-statement cache yet.
MMC currently screens at market cap $89.82B and trailing P/E 21.9. MPLT currently screens at market cap $1.24B.
Not investment advice. Open the MMC and MPLT stock pages for the full models.
Not investment advice.